Announcements
- EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
- EQS-Adhoc: BB Biotech AG publishes its interim report
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
- EQS-News: Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
- EQS-DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy
- EQS-Adhoc: BB Biotech AG publishes its 2023 annual report
- EQS-News: Investor interest returns – dividend yield remains high for 2024
More ▼
Key statistics
On Friday, BB Biotech AG (0JYO:LSE) closed at 40.68, 14.74% above the 52 week low of 35.45 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.68 |
---|---|
High | -- |
Low | -- |
Bid | 38.65 |
Offer | 42.70 |
Previous close | 41.25 |
Average volume | 4.51k |
---|---|
Shares outstanding | 55.40m |
Free float | 54.42m |
P/E (TTM) | -- |
Market cap | 2.25bn CHF |
EPS (TTM) | -3.76 CHF |
Annual div (ADY) | 2.00 CHF |
---|---|
Annual div yield (ADY) | 4.85% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 20 minutes, as of Apr 26 2024 17:38 BST.
More ▼